Description
The product is intended for in vitro diagnostic use in the quality control of serum on clinical chemistry and immunoassay systems. The assayed liquid protein controls are for the control of accuracy. For TRFIA assay, antibody can be diluted to 1:50-1:100, and dilution rate should be adjusted based on different testing method.
Target
2019-nCoV NP
Isotypes/Mimetics
Human IgG, Human IgM
Animal-Derived Biomaterials Used
No
Sequence Available
Yes
Original Discovery Method
Unknown
Antibody/Binder Origins
Unknown discovery source/method, In vitro recombinant expression, Animal-derived biomaterials used in production or final formulation